ElevateBio is accelerating the rate of innovation in cell and gene therapy with a disruptive capital-efficient model

Elevate right from the start.

Latest News: ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference Read More

We provide the tools, time, and environment to innovate and accelerate development of life-saving therapies

Pioneering science

Together with scientific innovators and our strategic partners, we are rapidly building a diverse portfolio of companies advancing immunotherapies, regenerative medicine products, in vivo viral-based therapies, and other cutting-edge cell and gene therapies from preclinical to commercialization.

Advancing technology

We’re pioneering new methods to develop next generation, cell, viral, and regenerative therapies. We offer expertise to our portfolio companies and partners to accelerate the development of cell and gene therapies, from cGMP manufacturing suites to protein engineering, virology, and immunology labs.

what is basecamp?

BaseCamp provides a home for scientific founders to elevate their vision

ElevateBio BaseCamp – the heart of our operations – is a dedicated cell and gene therapy research, process development, and production center that addresses the primary obstacles in cell and gene therapy and regenerative medicine: integrated research, process development and manufacturing.

Enabled By

ElevateBio

Our portfolio companies benefit from our entrepreneurial and flexible culture. We accelerate early-stage companies through capital and expertise, allowing them to focus on science, research, and development.

Innovator in T-Cell Immunotherapies Established Out of Technology from the Baylor College of Medicine’s Center for Cell and Gene Therapy

Learn More

Novel T Cell Immunotherapies Being Developed with Technology from The Fred Hutchinson Cancer Center

LEarn more

News

& Media

Stay up to date with news from our research, process development, cGMP manufacturing, clinical development, regulatory affairs, and commercial operations.

Webcast Event

Morgan Stanley 18th Annual Global Healthcare Conference

August 25, 2020

ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

May 26, 2020

ElevateBio to Present at the Jefferies Virtual Healthcare Conference

March 30, 2020

ElevateBio Closes $170 Million Series B Financing

March 26, 2020

European Medicines Agency Grants Orphan Drug Designation to AlloVir’s Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy

March 5, 2020

ElevateBio Appoints Kareem Reda as Chief Business Officer